PRWeb The Leader Press Release Distribution
See How PRWeb Works

We're here to help 1-866-640-6397

Login Create Free Account


All Press Releases for October 30, 2009 Add to my Yahoo! Subscribe to this News Feed Subscribe to this News Feed   
 

New MyKidz Comfort Patch™ Soothes Little Stuffy Noses this Cold and Flu Season

Comfort Patch™ is a new, safe, non-drug option that soothes kids' noses and throats with vapors that work up to 8 hours.

Monmouth Junction, NJ (Vocus/PRWEB ) October 30, 2009 -- This cold and flu season has come on strong, and the spread of the H1N1 virus has caused further concern especially among parents of young children. Unfortunately, there are fewer and fewer treatment options for these young kids driven by recent FDA safety concerns and label changes restricting use of over-the-counter cough and cold products to children under 4 years of age. Parents are looking for safe, effective, simple products to help soothe their kids, especially through the night so that they can get a good night's sleep.

News Image

New Comfort Patch™ is a safe, non-drug option that soothes kids' noses and throats with vapors that work up to 8 hours. Vapors penetrate nasal passages through the night, so parents and kids can get a good night's sleep. MyKidz, the makers of Comfort Patch, is addressing the concerns of a new generation of moms that diligently stay informed on health issues and look for drug-free, convenient options for their kids. In recent testing, nearly 90 percent* of moms rated Comfort Patch as better than other products for being mess-free and easy to use. In addition, the new MyKidz Cold & Flu Prep Center, which can be found on Facebook, will help moms navigate the news by providing the latest on prevention issues, as well as tips for treating and soothing kids when they begin to show symptoms.

"Reading about the spread and dangers of H1N1 virus and the seasonal flu can be very scary and figuring out what's right for their kids is top of mind for parents," said Dennis O'Donnell, president of NextWave Pharmaceuticals' OTC division. "We want to do our part to weed through the information and educate parents on things they can do preventatively and ways to comfort their kids if they do get sick. Comfort Patch is a drug-free option that parents should consider to help soothe little stuffy noses this season."

Comfort Patch is safe for kids ages 2 and up. Parents apply the soothing vapor patch to their child's pajamas and little throats and noses will be comforted all night long. The easy, no-mess application adheres to clothing, not children's skin. More information and a list of retailers is available at www.comfortpatch.com.

ABOUT NextWave Pharmaceuticals

NextWave Pharmaceuticals is a specialty pharmaceutical company with a broad line of pediatric products in development. NextWave licenses and develops unique products that address many of the compliance, convenience, dosing and safety issues that consumers face today.

*Persuadable Research Corp. National Study, 2008.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/Q3Jhcy1NYWduLVBpZ2ctRmFsdS1Qcm9mLUNvdXAtWmVybw==

Technorati Tags

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl


OPTIONS
Printer Friendly Printer Friendly Version
Adobe PDF Download PDF Version
Adobe PDF Download Reader Version
Blog This BlogThis
Share This ShareThis
CONTACT INFORMATION
April Sciacchitano
CRT/tanaka for NextWave Pharmaceuticals
757-640-1982 x60
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your PRWeb News Management Console.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Close Move